ArticleThe Annals of pharmacotherapy2022

Comment: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.

Brittany D Bissell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.